Document Detail


Control of plasma nitric oxide bioactivity by perfluorocarbons: physiological mechanisms and clinical implications.
MedLine Citation:
PMID:  15557364     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Perfluorocarbons (PFCs) are promising blood substitutes because of their chemical inertness and unparalleled ability to transport and upload O2 and CO2. Here, we report that PFC emulsions also efficiently absorb and transport nitric oxide (NO). METHODS AND RESULTS: Accumulation of NO and O2 in PFC micelles results in rapid NO oxidation and generation of reactive NO(x) species. Such micellar catalysis of NO oxidation leads to formation of vasoactive S-nitrosothiols (RSNO) in vitro and in vivo as detected electrochemically. The efficiency of PFC-mediated S-nitrosation depends on the amount of PFC in aqueous solution. The optimal PFC concentration that produced the maximum level of RSNO was approximately 1% (vol/vol). Larger PFC amounts were progressively less efficient in generating RSNO and functioned simply as NO sink. These results explain the characteristic hemodynamic effects of PFCs. Intravenous bolus application of PFC (0.14 g/kg, approximately 1% vol/vol) to Wistar-Kyoto rats decreased mean arterial pressure significantly (-10 mm Hg over 40 minutes). PFC-induced hypotension could be further stimulated (-17 mm Hg over 140 minutes) by exogenous thiols (cysteine and glutathione). In contrast, a larger amount of PFC (1 g/kg, approximately 7% vol/vol) exhibited a strong hypertensive effect (11 mm Hg over 40 minutes). CONCLUSIONS: The present study reveals a physiologically significant pool of endogenous plasma NO and underscores the crucial role of the circulating hydrophobic phase in modulating its bioactivity. The results also establish PFC as a conceptually new pharmacological tool for various cardiovascular complications associated with NO imbalance.
Authors:
Olga Rafikova; Elena Sokolova; Ruslan Rafikov; Evgeny Nudler
Related Documents :
10756274 - Basal nitric oxide production is enhanced by hydraulic pressure in cultured human perio...
8567524 - Effects of hypoxia and vascular tone on endothelium-dependent and -independent response...
21107584 - Daytime baroreflex sensitivity in patients with primary insomnia.
10691794 - Blood pressure control in enos knock-out mice: comparison with other species under no b...
24687584 - Smooth muscle bk channel activity influences blood pressure independent of vascular ton...
15617804 - A fuzzy logic-based model for the multistage high-pressure inactivation of lactococcus ...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.     Date:  2004-11-22
Journal Detail:
Title:  Circulation     Volume:  110     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-12-07     Completed Date:  2005-06-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3573-80     Citation Subset:  AIM; IM    
Affiliation:
Department of Biochemistry, New York University Medical Center,New York, NY 10016, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Biological Transport
Blood Pressure / drug effects
Blood Substitutes / administration & dosage,  chemistry,  pharmacology*
Electrochemistry
Fluorocarbons / administration & dosage,  chemistry,  pharmacology*
Injections, Intravenous
Male
Micelles
Nitric Oxide / blood,  chemistry,  metabolism*
Oxidation-Reduction
Rats
Rats, Inbred WKY
S-Nitrosothiols / blood,  chemistry
Chemical
Reg. No./Substance:
0/Blood Substitutes; 0/Fluorocarbons; 0/Micelles; 0/S-Nitrosothiols; 10102-43-9/Nitric Oxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study.
Next Document:  Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressur...